Effect of clindamycin on human osteoblasts treated with zoledronate: An in vitro study
Treatment with low-dose clindamycin can reverse the negative impact of zoledronate on osteoblast proliferation and differentiation. Follow-up animal studies and clinical trials are needed before topical clindamycin can be considered as a possible therapeutic resource for BP-treated patients who require a GBR procedure.
Authors
- Concepción Ruíz (ORCID: https://orcid.org/0000-0003-4332-6812)
- Enrique García‐Recio (ORCID: https://orcid.org/0000-0001-9850-1214)
- Elvira De Luna‐Bertos (ORCID: https://orcid.org/0000-0002-4381-5942)
- Francisco Javier Manzano‐Moreno (ORCID: https://orcid.org/0000-0002-3176-7613)
- Anabel González‐Acedo (ORCID: https://orcid.org/0000-0002-8132-305X)
- Hunayda Bumedien-Abdelgani
Institutions
- Universidad de Granada (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
Publication Details
- Journal
- Archives of Oral Biology
- Published
- 2025-04-05
- DOI
- https://doi.org/10.1016/j.archoralbio.2025.106247
- Citations
- 1
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.05